Montpellier, France

Jean-Marie Galano

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, Centre National De La Recherche Scientifique, Ecole Nationale Superieure De Chimie De Montpellier. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marie Galano. Retrieved from https://idiyas.com/inventor/jean-marie-galano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Marie Galano

Introduction

Jean-Marie Galano is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pain management through his innovative research and discoveries. His work focuses on the development of new therapeutic compounds that can alleviate pain disorders.

Latest Patents

Jean-Marie Galano holds a patent for lipopeptide compounds aimed at treating pain disorders. This invention is based on the discovery of a new bacterial compound with analgesic properties, which could serve as a novel tool for managing conditions such as visceral pain. The research highlights the mechanisms involved in the analgesic properties of the probiotic strain Nissle 1917 (EcN). The inventors characterized the amino fatty acids produced by EcN, which exhibit these analgesic properties. One of the compounds identified inhibits hypersensitivity to colorectal distension induced by capsaicin, a potent nociceptive agent, acting via the GABA B receptor. Furthermore, the compound demonstrates the ability to cross cellular epithelial barriers, such as the intestinal epithelium. Thus, the invention relates to a lipopeptide compound derived from gamma-aminobutyric acid, which can be utilized for treating various pain disorders, including somatic and visceral pain.

Career Highlights

Throughout his career, Jean-Marie Galano has worked with esteemed institutions such as the National Institute of Health and Medical Research (INSERM) and the University Hospital of Toulouse. His research has significantly advanced the understanding of pain mechanisms and the potential for new treatments.

Collaborations

Jean-Marie has collaborated with notable colleagues, including Nicolas Cenac and Justine Bertrand-Michel, to further his research and innovations in the field of pain management.

Conclusion

Jean-Marie Galano's contributions to the field of pain treatment through his innovative lipopeptide compounds highlight the importance of research in developing new therapeutic options. His work continues to pave the way for advancements in pain management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…